Chemotherapy With Or Without Pembrolizumab Followed By Maintenance With Olaparib Or Placebo For First-Line Treatment Of Advanced BRCA Non-Mutated Epithelial Ovarian Cancer: Results From The Randomized Phase 3 ENGOT-OV43/GOG-3036/KEYLYNK-001 Study
1. 系统已在2025-04-02 16:55:07对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.ijgc.2025.101704
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1048891X25008217
其他信息:
出版社: Elsevier BV
作者: Ignace Vergote; David Cibula; Matthew Powell; Els Van Nieuwenhuysen; Samet Topuz; Antonio González-Martín; Keiichi Fujiwara; Sufia Safina; Andrea Bagaméri; Matthew Oliver; Jung-Yun Lee; Giovanni Scambia; Jacob Korach; Chien-Hsing Lu; Nicoletta Colombo; Radoslaw Madry; Jing Wei; Sarper Toker; Karin Yamada; John Moroney